Private Equity in Asia

Fact Sheet

Experience

  • Clean Tech | Renewable Energy

  • Private Equity Transactions

    • KKR and Global Atlantic, a retirement and life insurance company, in their strategic partnership with Japan Post Insurance.
    • HarbourVest Partners, TPG NewQuest and Committed Advisors as the lead investors in CSP Fund II, a $700 million continuation vehicle sponsored by a partnership between Capital Square Partners and Basil Technology Partners to acquire a portfolio of companies from existing funds.
    • True North in its acquisition of a significant minority stake in Accion Group Holdings, a Pittsburg-based digital and innovation engineering company, from TA Associates and other shareholders.
    • D1 Capital as the lead investor in a convertible preferred shares investment in XTransfer, a China-based FinTech company providing cross-border payment services.
    • Carlyle, as majority owner of Syniverse, in Syniverse’s $2.85 billion merger, later terminated, with special purpose acquisition company M3-Brigade Acquisition II Corp. resulting in Syniverse becoming a publicly traded company.
    • Wilsonart, a Clayton, Dubilier & Rice portfolio company, in the $150 million sale of its Asia Business to Aica Kogyo and the Development Bank of Japan.
    • FWD in its acquisition of MetLife Hong Kong.
    • HarbourVest Partners in its co-investment in connection with the acquisition of an Australian wine producer.
    • A private equity fund’s proposed acquisition of a significant stake in the financial services business being spun-out from a listed Chinese technology company. (Terminated)
    • HarbourVest Partners in its co-investment in a payroll business process outsourcing company in Australia.
    • A private family office in its investment in Grab, a Singapore-based technology company that offers ride-hailing, ride-sharing and logistics services.
    • A private equity portfolio company in its proposed acquisition of a chemicals company in Southeast Asia.
    • HarbourVest Partners in its co-investment with a Southeast Asian private equity fund in the buyout of an education group in Malaysia.
    • HarbourVest Partners in its investment in the acquisition of an Australian healthcare company.
    • Capital Group in its investment in Go-Jek, an Indonesian hyperlocal transport, logistics and payments startup that operates a leading online delivery and ride-hailing platform in Southeast Asia.
    • Dover Corporation in its buyout of its Chinese partner’s 33% interest in Tokheim Hengshan Technology (Guangzhou) Co., Ltd.
    • Hony Capital in its capacity as a strategic shareholder in the acquisition of naked Hub by WeWork Greater China.
    • Capital Group in its acquisition of an equity stake in Intas Pharmaceuticals, one of the largest pharmaceutical companies in India, from ChrysCapital, an India-focused private equity firm.
    • Hony Capital in its investments in Nasdaq-listed FibroGen, a U.S.-based biopharmaceutical company.
    • Ally Bridge in its PIPEs transaction with Nasdaq-listed Sorrento Therapeutics, a U.S. biotechnology company.
    • Goldman Sachs Principal Investments in its investment in a mobile video streaming company in China.
    • The D. E. Shaw Group in the restructuring of Kaisa, a Hong Kong-listed PRC property developer.
    • Hony Capital in its strategic investment in, and related cooperation arrangements with, as well as follow-on investment and subsequent corporate restructuring transactions involving, the WeWork Companies.
    • Capital International in its approximately $200 million acquisition of a minority stake in Mankind Pharma, an Indian pharmaceutical company.
    • Russia China Investment Fund in its investment in TutorGroup.
    • Clearwater Capital Partners in the establishment of an Indian credit platform, and the approximately $300 million collective co-investment by Clearwater Capital Partners and two other large global investors.
    • Nereus Capital in its joint venture with Hareon Solar and Treasury Group to invest in solar projects in India.icon-alt
    • AIF Capital as a selling shareholder in the sale of certain female healthcare businesses of Famy Care, the world’s largest producer of oral contraceptive pills, to Mylan.
    • Credit Suisse in the sale of its Asian PE Portfolio to HarbourVest and Asia Growth Capital.
    • FLAG Capital Management in its acquisition of Squadron Capital, a Hong Kong-based private equity investment firm.
    • EIG in its sale of a minority interest to China Investment Corporation.
    • HarbourVest Partners in connection with various co-investment transactions in the healthcare and specialty foods sectors in Australia.
    • Alibaba in its sale of a $1.6 billion stake to a consortium of investors including Silver Lake Technology Management, Digital Sky Technologies, Temasek Holdings and Yunfeng Capital.
    • Asia Mezzanine Capital in its investment in SFO Technologies Private Limited of India, an IT design and manufacturing services provider to leading original equipment manufacturers worldwide.
    • Prudential Financial in its strategic cooperation with Fosun Group, China’s leading private investment company, to establish a $600 million private equity fund and a related joint venture in the PRC.
    • Headland Capital Partners, the former Asian arm of HSBC Private Equity, in its spin-off from HSBC.
    • HarbourVest Partners and Paul Capital Advisors, as part of a consortium providing equity financing for the formation of NewQuest Asia Fund and its acquisition of Bank of America Merrill Lynch's non-real estate private equity portfolio in Asia.
    • Providence Equity Partners in its $430 million investment in Aditya Birla Telecom, a subsidiary of Idea Cellular.
    • HarbourVest Partners in its co-investment with Champ Ventures in Sea Swift Pty.
    • One Equity Partners, the principal investment arm of JPMorgan, in its spin-out and related primary and secondary transactional matters.

  • Private Equity Funds

    • KKR Asia Pacific Infrastructure Investors II, a $6.4 billion fund focused on infrastructure-related investments across Asia Pacific.
    • Lightspeed India Partners Fund IV, a $500 million India venture fund.
    • Advantage Partners’ Asia Fund, a $380 million fund investing in small to mid-cap companies across Asia.
    • VIG Partners International Fund III, a $600 million fund targeting investment in Korea.
    • Baring Asia Private Equity Fund VI, a $4 billion pan-Asia private equity fund.
    • CDH Fund V, a $2.6 billion growth capital fund focused on investments in China.
    • Baring Asia Private Equity Fund V, a $2.5 billion Asia growth capital fund.
    • Hony Capital in the formation of Hony Capital Fund V, a $2.4 billion China growth capital fund.
    • North Haven Private Equity Asia IV, a $1.7 billion Asia buyout fund.
    • CDH China Fund III, a $1.6 billion China growth capital fund.
    • The HSBC Private Equity Fund 6, a $1.5 billion Asia growth capital fund.
    • CDH Fund IV, a $1.45 billion China growth capital fund.
    • Hony Capital Fund 2008, a $1.4 billion China growth capital fund.
    • North Haven Private Equity Asia III, a $1.4 billion Asia buyout fund.
    • SAIF Partners IV, a $1.3 billion Asia and India growth capital fund.
    • Navis Asia Fund VI, a $1.2 billion Asia buyout fund.
    • Navis Asia Fund V, a $1 billion Asia buyout fund.
    • Hony Capital Fund III, a $580 million China growth capital fund.
    • China Harvest Fund II, a $576 million Asia growth capital fund.
    • Baring India Private Equity Fund III, a $562 million India and South Asia growth capital fund.
    • CDH Venture Partners II, a $505 million China venture fund.
    • Southern Capital Fund III, a $408 million Asia buyout fund.
    • Mulberry Asia Fund II, a $291 million Asia buyout fund.
    • CDH Venture Partners I, a $210 million China venture fund.
    • Carlyle Beijing Partners Fund, a ¥2.6 billion China buyout and growth capital fund.
    • Hangzhou Riverbank Equity Investment Partnership, a ¥1.7 billion China buyout and growth capital fund.
    • Fosun-Carlyle (Shanghai) Equity Investment Fund, a $100 million China buyout/growth capital fund.